핵의학

본문글자크기
  • [J Clin Endocrinol Metab.] Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study

    2021년 08월호
    [J Clin Endocrinol Metab.] Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study

    이화의대 / 서기현, 김혜옥*

  • 출처
    J Clin Endocrinol Metab.
  • 등재일
    2021 Jun 16
  • 저널이슈번호
    106(7):e2580-e2588. doi: 10.1210/clinem/dgab192.
  • 내용

    바로가기  >

    Abstract
    Purpose: This study investigated radioactive iodine treatment (RAIT) patterns and the secondary cancer incidence among children and young adults receiving RAIT after thyroidectomy for thyroid cancer.

    Methods: This population-based cohort study used the Health Insurance Review and Assessment database of South Korea to identify a total of 18 617 children and young adults (0-29 years) who underwent thyroidectomy for thyroid cancer between 2008 and 2018. We recorded age at surgery, sex, the interval from surgery to RAIT, the doses of RAI, the number of RAIT sessions, and secondary cancer incidence.

    Results: A total of 9548 (51.3%) children and young adults underwent 1 or more RAIT sessions. The initial dose of RAIT was 4.35 ± 2.19 GBq. The overall RAIT frequency fell from 60.9% to 38.5%, and the frequency of high-dose RAIT (>3.7 GBq) fell from 64.2% to 36.5% during the observational period. A total of 124 cases of secondary cancer developed during 120 474 person-years of follow-up; 43 (0.5%) in the surgery cohort and 81 (0.8%) in the RAIT cohort. Thus, the RAIT cohort was at an increased risk of secondary cancer (adjusted hazard ratio 1.52 [95% confidence interval 1.03-2.24], P = 0.035).

    Conclusion: The proportion of children and young adults receiving RAIT, and the RAI dose, fell significantly over the observational period. RAIT was associated with secondary cancers. This is of major concern in the context of child and young adult thyroid cancer survivors.

     

     

     

     

    Affiliations

    Gi Hyeon Seo  1 , Kyoung Ae Kong  2 , Bom Sahn Kim  3 , Seo Young Kang  3 , Byung Seok Moon  3 , Hai-Jeon Yoon  3 , Hye Ok Kim  3
    1 Health Insurance Review and Assessment Service, Seoul, Korea.
    2 Department of Preventive Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
    3 Department of Nuclear Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.

  • 키워드
    iodine therapy; pediatric thyroid cancer; secondary cancer; thyroid neoplasm.
  • 연구소개
    본 연구는 우리나라 건강보험 빅데이터를 이용하여 소아 및 젊은 성인 갑상선암 환자의 방사성요오드 치료에 대한 real-world data를 보고자 하였습니다. 갑상선암으로 방사성요오드 치료를 시행 받은 30세 미만 젊은 환자를 대상으로 후향적 코호트를 구성하여 방사성요오드 치료 현황 및 패턴 변화, 이차암 발생과의 상관관계를 살펴본 연구입니다.
  • 편집위원

    갑상선암 치료에 효과가 입증된 방사성요오드 치료가 소아 청소년에서 악성종양 발생에 대한 임상연구임. 방사성요오드 치료군는 수술군에 비해 이차암의 발생 위험성이 1.52배 높음을 보여준 연구임. 방사성요오드 치료 및 종양 역학에 관심이 있는 전문가에게 관심을 끌 연구로 생각됨.

    덧글달기2021-07-27 14:47:22

  • 덧글달기
    덧글달기
       IP : 18.191.135.224

    등록